skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 2,288  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Heart remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy
Material Type:
Article
Add to My Research

Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy

Heart (British Cardiac Society), 2024-05, p.heartjnl-2024-323975 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-323975 ;PMID: 38749654

Full text available

2
Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up
Material Type:
Article
Add to My Research

Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up

Heart (British Cardiac Society), 2024-05, Vol.110 (11), p.792-799 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323606 ;PMID: 38388470

Full text available

3
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Material Type:
Article
Add to My Research

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

Heart (British Cardiac Society), 2024-05, p.heartjnl-2023-323796-2023-323796 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323796 ;PMID: 38729636

Full text available

4
Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors
Material Type:
Article
Add to My Research

Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors

Heart (British Cardiac Society), 2024-05, Vol.110 (10), p.726-734 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323474 ;PMID: 38503487

Full text available

5
Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease
Material Type:
Article
Add to My Research

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease

Heart (British Cardiac Society), 2024-04, p.heartjnl-2023-323783 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323783 ;PMID: 38688703

Full text available

6
Exercise intolerance in a man with ischaemic cardiomyopathy and biventricular pacing
Material Type:
Article
Add to My Research

Exercise intolerance in a man with ischaemic cardiomyopathy and biventricular pacing

Heart (British Cardiac Society), 2024-04, Vol.110 (10), p.693-750 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-324056 ;PMID: 38663974

Full text available

7
Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study
Material Type:
Article
Add to My Research

Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study

Heart (British Cardiac Society), 2024-04, p.heartjnl-2023-323577 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323577 ;PMID: 38631899

Full text available

8
Preconception counselling in women of reproductive age attending cardiology clinics in Scotland
Material Type:
Article
Add to My Research

Preconception counselling in women of reproductive age attending cardiology clinics in Scotland

Heart (British Cardiac Society), 2024-04, p.heartjnl-2023-323666 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323666 ;PMID: 38627021

Full text available

9
Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2024-04, p.heartjnl-2023-323856 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323856 ;PMID: 38589224

Full text available

10
25 Residual structural, functional and myocardial tissue abnormalities in patients with dilated cardiomyopathy in clinical remission
Material Type:
Article
Add to My Research

25 Residual structural, functional and myocardial tissue abnormalities in patients with dilated cardiomyopathy in clinical remission

Heart (British Cardiac Society), 2024-03, Vol.110 (Suppl 1), p.A18-A19 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BSCMR.22

Full text available

11
27 Aberrant kinetic energy and haemodynamic forces revealed by 4-D flow CMR in non- obstructive HCM with normal diastolic function on echocardiogram
Material Type:
Article
Add to My Research

27 Aberrant kinetic energy and haemodynamic forces revealed by 4-D flow CMR in non- obstructive HCM with normal diastolic function on echocardiogram

Heart (British Cardiac Society), 2024-03, Vol.110 (Suppl 1), p.A20-A22 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BSCMR.24

Full text available

12
7 Prognostic value of left atrial structure and function in dilated cardiomyopathy
Material Type:
Article
Add to My Research

7 Prognostic value of left atrial structure and function in dilated cardiomyopathy

Heart (British Cardiac Society), 2024-03, Vol.110 (Suppl 1), p.A3-A3 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BSCMR.5

Full text available

13
26 Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathy
Material Type:
Article
Add to My Research

26 Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathy

Heart (British Cardiac Society), 2024-03, Vol.110 (Suppl 1), p.A19-A20 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BSCMR.23

Full text available

14
14 Myocardial sheetlet abnormality as a marker of sarcomere dysfunction in carriers of rare HCM-causing sarcomere gene variants before phenotypic conversion
Material Type:
Article
Add to My Research

14 Myocardial sheetlet abnormality as a marker of sarcomere dysfunction in carriers of rare HCM-causing sarcomere gene variants before phenotypic conversion

Heart (British Cardiac Society), 2024-03, Vol.110 (Suppl 1), p.A7-A9 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BSCMR.12

Full text available

15
Young adult with left ventricular dysfunction
Material Type:
Article
Add to My Research

Young adult with left ventricular dysfunction

Heart (British Cardiac Society), 2024-02, Vol.110 (5), p.322-384 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323471 ;PMID: 38346774

Full text available

16
Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry
Material Type:
Article
Add to My Research

Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry

Heart (British Cardiac Society), 2024-02, Vol.110 (5), p.359-365 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323049 ;PMID: 37827557

Full text available

17
Ventricular hypertrophy in a young weightlifter
Material Type:
Article
Add to My Research

Ventricular hypertrophy in a young weightlifter

Heart (British Cardiac Society), 2024-02, Vol.110 (3), p.194-220 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-323413 ;PMID: 38199673

Full text available

18
Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation
Material Type:
Article
Add to My Research

Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation

Heart (British Cardiac Society), 2024-02, Vol.110 (3), p.195-201 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. 2024 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-322857 ;PMID: 37567614

Full text available

19
Aetiology, ejection fraction and mortality in chronic heart failure: a mediation analysis
Material Type:
Article
Add to My Research

Aetiology, ejection fraction and mortality in chronic heart failure: a mediation analysis

Heart (British Cardiac Society), 2024-02, Vol.110 (4), p.290-298 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-322803 ;PMID: 37722825

Full text available

20
Widening ethnic inequities in heart failure incidence in New Zealand
Material Type:
Article
Add to My Research

Widening ethnic inequities in heart failure incidence in New Zealand

Heart (British Cardiac Society), 2024-02, Vol.110 (4), p.281-289 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-322795 ;PMID: 37536757

Full text available

Results 1 - 20 of 2,288  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1969  (38)
  2. 1969 To 1981  (139)
  3. 1982 To 1994  (194)
  4. 1995 To 2008  (811)
  5. After 2008  (1,108)
  6. More options open sub menu

Language 

  1. Japanese  (268)
  2. Norwegian  (2)
  3. More options open sub menu

Searching Remote Databases, Please Wait